πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 169 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10584147

Procoagulant fusion compound

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10583145

Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes,

The Board of Regents of the University of Texas System Β· Granted Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10568943

Factor IX polypeptides and methods of use thereof

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10568831

Method to enhance swallowing safety and appeal of beverages for treating dysphagia based o

Regents of the University of Minnesota Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10561714

Factor IX polypeptides and methods of use thereof

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10548954

Factor IX polypeptides and methods of use thereof

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10548953

Factor VIII-XTEN fusions and uses thereof

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10532056

Therapeutic compositions, combinations, and methods of use

VERASTEM, INC. Β· Granted Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10532079

Extracts and beverages containing 2,5-piperazinedione, 3,6-bis(phenylmethyl)-, (3S,6S)-

SUNTORY BEVERAGE & FOOD ASIA PTE. LTD. Β· Granted Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10526655

Methods for evaluating COPD status

Veracyte, Inc. Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10499682

Micronutrient formulation in electronic cigarettes

New Age Beverage Corporation Β· Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10494316

Process for the preparation of deuterated ethanol from D2O

Deuteria Beverages, LLC Β· Granted Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10471035

Compositions and methods for using esters of meroterpenes and of other resveratrol analogu

Sunny BioDiscovery Β· Granted Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10464967

Non-hormonal steroid modulators of NF-ΞΊΞ² for treatment of disease

ReveraGen BioPharma, Inc. Β· Granted Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10457745

Anti-complement C1s antibodies

Bioverativ USA Inc. Β· Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10450382

Anti-complement C1s antibodies

Bioverativ USA Inc. Β· Granted Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10421798

Factor VIII compositions and methods of making and using same

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10406158

Methods and compositions for treating abnormal cell growth

VERASTEM, INC. Β· Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10391152

Methods of using a fixed dose of a clotting factor

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10370430

Recombinant factor VIII proteins

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10325687

Population pharmacokinetics tools and uses thereof

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10308909

Dried spore germinative compound mixtures

Envera LIC, LLC Β· Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10301248

Compositions and methods comprising resveratrol

Biocogent, LLC Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10287564

Procoagulant compounds

BIOVERATIV THERAPEUTICS INC. Β· Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted